Suzanne Kamel-Reid
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Molecular BiologyGoogle:
"Suzanne Kamel-Reid"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Reis PP, Tokar T, Goswami RS, et al. (2020) A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation. Scientific Reports. 10: 1713 |
Dhani NC, Hirte HW, Wang L, et al. (2020) Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago and California Consortia (NCI9322/PHL86). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Nikbakht H, Jessa S, Sukhai MA, et al. (2020) Latency and interval therapy affect the evolution in metastatic colorectal cancer. Scientific Reports. 10: 581 |
Puckrin R, Atenafu EG, Claudio JO, et al. (2020) Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia. Haematologica |
Malone ER, Saleh RR, Yu C, et al. (2019) OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing. Current Oncology (Toronto, Ont.). 26: e618-e623 |
Murphy T, Zou J, Daher-Reyes GS, et al. (2019) Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML. Blood Advances. 3: 2307-2311 |
Moncur JT, Bartley AN, Bridge JA, et al. (2019) Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Archives of Pathology & Laboratory Medicine |
Rodriguez-Freixinos V, Lheureux S, Mandilaras V, et al. (2019) Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients. Gynecologic Oncology |
Perdrizet K, Stockley T, Law JH, et al. (2019) Non-small cell lung cancer (NSCLC) next generation sequencing (NGS) using the Oncomine Comprehensive Assay (OCA) v3: Integrating expanded genomic sequencing into the Canadian publicly funded health care model. Journal of Clinical Oncology. 37: 2620-2620 |
Campbell PA, Thavorn K, Lo B, et al. (2019) Abstract 3355: Challenges in the implementation of molecular diagnostic testing for non-small cell lung cancer Cancer Research |